BackAbCellera Biologics Overview

AbCellera Biologics Accounts Payable

AbCellera Biologics's accounts payable is $21M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$20.81M

Peer average

Loading

AbCellera Biologics Accounts Payable History

Loading

AbCellera Biologics vs. peers: Accounts Payable Comparison

Loading

AbCellera Biologics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AbCellera Biologics (ABCL) FAQ

AbCellera Biologics (ABCL) currently reports a accounts payable of $21M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore AbCellera Biologics's accounts payable history and peer comparisons.

AbCellera Biologics's accounts payable changed from $0 to $21M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AbCellera Biologics reported $21M in accounts payable as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AbCellera Biologics, and consider following ABCL for alerts when major investors trade the stock.